Day: Tubules
Startups
These Munich unicorns will shape the startup scene in 2026
Munich remains a unicorn hotspot: Based on a recent analysis of our Munich Startup Insights, we show you which startups have broken the billion-dollar valuation mark…
News
Tubulis increases Series C to 344 million euros
Munich-based biotech company Tubulis has increased its Series C financing round from €308 million to €344 million, thereby accelerating its development…
News
Tubulis receives record sum of 308 million euros
Munich-based biotech Tubulis is working on special antibody drug conjugates (ADCs) for cancer therapy. The company has now secured €308 million in funding…
News
3 Munich biotech startups honored with the European Lifestars Awards
Three Munich startups impressed at this year's European Lifestars Awards in London: Of all the applications and nominees received…
News
Tubulis increases Series B to 128 million euros
Tubulis is working on special antibody-drug conjugates for cancer therapy. The Munich-based biotech company has now completed an expanded and oversubscribed Series B2 financing round totaling…
News
Tubulis collaborates with Bristol Myers Squibb and receives up to $1 billion
Tubulis has entered into a strategic partnership with the American pharmaceutical company Bristol Myers Squibb. The startup, based at the IZB in…
News
How Munich biotech startups are fighting cancer
Munich is one of Germany's leading biotech hubs. Research is conducted here on a wide variety of medications and therapies, including cancer. We…
News
Tubulis closes Series B with 60 million euros
Tubulis secures €60 million ($63 million) in its Series B funding. The round is led by Andera Partners.…
financing
Tubulis receives millions in Series A
The series of investments for health and biotech startups continues: Now the biotech company Tubulis announced a Series A financing worth millions.
